$8.10
0.060.75%
Last update: Oct 30, 9:06 AM
Grifols SA (GRFS) Stock Price, Quote, News & History
GRFSNASDAQ
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
You can purchase shares of Grifols (NASDAQ:GRFS) through any online brokerage.
Other companies in Grifols’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Grifols has a consensus price target of $9.93.
The stock price for Grifols (NASDAQ: GRFS) is $8.1 last updated October 30, 2026 at 9:06 AM EDT.
There are no upcoming dividends for Grifols.
Grifols does not have any upcoming earnings scheduled.
There is no upcoming split for Grifols.
Grifols is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products...
